HK1201763A1 - Polyamine enhanced formulations for triptan compound iontophoresis - Google Patents

Polyamine enhanced formulations for triptan compound iontophoresis

Info

Publication number
HK1201763A1
HK1201763A1 HK15102214.9A HK15102214A HK1201763A1 HK 1201763 A1 HK1201763 A1 HK 1201763A1 HK 15102214 A HK15102214 A HK 15102214A HK 1201763 A1 HK1201763 A1 HK 1201763A1
Authority
HK
Hong Kong
Prior art keywords
iontophoresis
triptan compound
enhanced formulations
polyamine
polyamine enhanced
Prior art date
Application number
HK15102214.9A
Other languages
English (en)
Chinese (zh)
Inventor
‧塞布里
‧霍斯特曼
‧薩米提
Original Assignee
Nupathe Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nupathe Inc filed Critical Nupathe Inc
Publication of HK1201763A1 publication Critical patent/HK1201763A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrotherapy Devices (AREA)
HK15102214.9A 2008-06-19 2015-03-04 Polyamine enhanced formulations for triptan compound iontophoresis HK1201763A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12/214,555 US8366600B2 (en) 2008-06-19 2008-06-19 Polyamine enhanced formulations for triptan compound iontophoresis

Publications (1)

Publication Number Publication Date
HK1201763A1 true HK1201763A1 (en) 2015-09-11

Family

ID=41431954

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15102214.9A HK1201763A1 (en) 2008-06-19 2015-03-04 Polyamine enhanced formulations for triptan compound iontophoresis

Country Status (12)

Country Link
US (3) US8366600B2 (de)
EP (1) EP2296597A4 (de)
JP (2) JP5931439B2 (de)
CN (2) CN102065807B (de)
AU (2) AU2008358026B2 (de)
CA (1) CA2727926A1 (de)
EA (2) EA023339B1 (de)
HK (1) HK1201763A1 (de)
IL (1) IL209755A (de)
MX (1) MX2010013645A (de)
WO (1) WO2009154648A1 (de)
ZA (1) ZA201008859B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2285362B1 (de) * 2008-06-19 2017-08-09 LTS LOHMANN Therapie-Systeme AG Zusammensetzung zur transdermalen verabreichung kationischer wirkstoffe
NZ598622A (en) * 2009-08-10 2014-02-28 Nupathe Inc Methods for iontophoretically treating nausea and migraine
EA037149B1 (ru) * 2016-03-25 2021-02-11 Аминекс Терапьютикс, Инк. Биодоступные полиамины
WO2018006069A1 (en) 2016-06-30 2018-01-04 Teva Pharmaceuticals International Gmbh Improved formulations for transdermal pharmaceutical systems
EP3727330A1 (de) 2017-12-20 2020-10-28 LTS Lohmann Therapie-Systeme AG Einfrierstabile zusammensetzung zur iontophoretischen transdermalen abgabe einer triptanverbindung
CA3086494A1 (en) 2017-12-20 2019-06-27 Lts Lohmann Therapie-Systeme Ag Frigostable composition for iontophoretic transdermal delivery of a triptan compound
EP4221698A1 (de) 2020-09-30 2023-08-09 Aminex Therapeutics, Inc. Kombinationswirkstoff aus einem polyamintransporthemmer und dfmo
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
AU2022253899A1 (en) 2021-04-07 2023-10-26 Battelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4856188A (en) 1984-10-12 1989-08-15 Drug Delivery Systems Inc. Method for making disposable and/or replenishable transdermal drug applicators
US5651768A (en) 1983-08-18 1997-07-29 Drug Delivery Systems, Inc. Transdermal drug applicator and electrodes therefor
US5605536A (en) 1983-08-18 1997-02-25 Drug Delivery Systems Inc. Transdermal drug applicator and electrodes therefor
US4822802A (en) 1987-02-24 1989-04-18 Alza Corporation Method of fentanly administration for postoperative pain relief
US4927408A (en) 1988-10-03 1990-05-22 Alza Corporation Electrotransport transdermal system
EP0429842B1 (de) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Vorrichtung zur transdermalen Applikation von Protein- oder Peptid-Medikamenten
US5207752A (en) 1990-03-30 1993-05-04 Alza Corporation Iontophoretic drug delivery system with two-stage delivery profile
DE4014913C2 (de) 1990-05-10 1996-05-15 Lohmann Therapie Syst Lts Miniaturisiertes transdermales therapeutisches System für die Iontophorese
ATE160510T1 (de) 1992-06-02 1997-12-15 Alza Corp Abgabevorrichtung zur elektrischen übertragung von arzneimitteln
US5807571A (en) 1993-05-06 1998-09-15 Lts Lohmann Therapie-Systeme Gmbh Transdermal therapeutic systems for administering indole serotonin agonists
US5458569A (en) 1993-06-08 1995-10-17 Becton Dickinson And Company Wearable iontophoresis system
US5533971A (en) 1993-09-03 1996-07-09 Alza Corporation Reduction of skin irritation during electrotransport
DE69429603T2 (de) * 1993-09-22 2002-08-14 Hisamitsu Pharmaceutical Co., Inc. Iontophoresematrix
US5697896A (en) 1994-12-08 1997-12-16 Alza Corporation Electrotransport delivery device
IE960312A1 (en) 1995-06-02 1996-12-11 Alza Corp An electrotransport delivery device with voltage boosting¹circuit
US6216033B1 (en) 1996-05-22 2001-04-10 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6425892B2 (en) 1995-06-05 2002-07-30 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
AU699774B2 (en) 1995-06-05 1998-12-17 Alza Corporation Device for transdermal electrotransport delivery of fentanyl and sufentanil
US6245347B1 (en) 1995-07-28 2001-06-12 Zars, Inc. Methods and apparatus for improved administration of pharmaceutically active compounds
US5941843A (en) 1996-07-12 1999-08-24 Empi, Inc. Iontophoresis electrode
US5882677A (en) * 1997-09-30 1999-03-16 Becton Dickinson And Company Iontophoretic patch with hydrogel reservoir
DE19828273B4 (de) * 1998-06-25 2005-02-24 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System, enthaltend Hormone und Kristallisationsinhibitoren
SE9802864D0 (sv) 1998-08-27 1998-08-27 Pharmacia & Upjohn Ab Transdermally administered tolterodine as antimuscarinic agent for the treatment of overactive bladder
JP4414517B2 (ja) * 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US6421561B1 (en) 1999-12-30 2002-07-16 Birch Point Medical, Inc. Rate adjustable drug delivery system
DE10035891A1 (de) * 2000-07-24 2002-02-14 Lohmann Therapie Syst Lts Medizinischer Haftkleber mit einer zweiphasigen Klebermatrix aus Polyacrylaten und Polyaminsalzen
IT1319210B1 (it) * 2000-10-13 2003-09-26 Italiano Biochimico Lisapharma Pellicola per la somministrazione dermica e transdermica di principiattivi.
US6653014B2 (en) 2001-05-30 2003-11-25 Birch Point Medical, Inc. Power sources for iontophoretic drug delivery systems
EP1435945B1 (de) 2001-06-05 2008-08-13 Aung-din, Ronald Topische migränetherapie
US20030065285A1 (en) * 2001-07-23 2003-04-03 Higuchi William I. Method and apparatus for increasing flux during reverse iontophoresis
WO2004002571A1 (en) 2002-06-28 2004-01-08 Alza Corporation A reservoir for use in an electrotransport drug delivery device
US6745071B1 (en) 2003-02-21 2004-06-01 Birch Point Medical, Inc. Iontophoretic drug delivery system
US20040242770A1 (en) 2003-04-16 2004-12-02 Feldstein Mikhail M. Covalent and non-covalent crosslinking of hydrophilic polymers and adhesive compositions prepared therewith
US8734421B2 (en) 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US20050228336A1 (en) 2004-04-07 2005-10-13 Preston Keusch Electrically assisted lidocaine and epinephrine delivery device having extended shelf-stability
US7906137B2 (en) * 2004-05-21 2011-03-15 Mediplex Corporation, Korea Delivery agents for enhancing mucosal absorption of therapeutic agents
US7856263B2 (en) 2005-04-22 2010-12-21 Travanti Pharma Inc. Transdermal systems for the delivery of therapeutic agents including granisetron using iontophoresis
EP1931416A2 (de) 2005-09-30 2008-06-18 Tti Ellebeau, Inc. Iontophoreseverfahren und gerät für die systemische abgabe von wirkstoffen
WO2007041434A2 (en) * 2005-09-30 2007-04-12 Tti Ellebeau, Inc. Iontophoresis apparatus and method for delivery of angiogenic factors to enhance healing of injured tissue
CA2650412C (en) 2006-04-13 2016-09-27 Nupathe, Inc. Transdermal methods and systems for the delivery of anti-migraine compounds
EP2285362B1 (de) 2008-06-19 2017-08-09 LTS LOHMANN Therapie-Systeme AG Zusammensetzung zur transdermalen verabreichung kationischer wirkstoffe

Also Published As

Publication number Publication date
AU2015224400A1 (en) 2015-10-29
JP6002179B2 (ja) 2016-10-05
JP2014237675A (ja) 2014-12-18
CA2727926A1 (en) 2009-12-23
US20170112779A1 (en) 2017-04-27
IL209755A0 (en) 2011-02-28
EA023339B1 (ru) 2016-05-31
US8366600B2 (en) 2013-02-05
AU2015224400B2 (en) 2017-06-01
AU2008358026A1 (en) 2009-12-23
JP2011524901A (ja) 2011-09-08
EA201590907A1 (ru) 2016-02-29
ZA201008859B (en) 2016-03-30
EP2296597A1 (de) 2011-03-23
EP2296597A4 (de) 2013-10-16
AU2008358026B2 (en) 2015-06-18
JP5931439B2 (ja) 2016-06-08
MX2010013645A (es) 2011-02-15
WO2009154648A1 (en) 2009-12-23
CN104027885A (zh) 2014-09-10
EA201100055A1 (ru) 2011-08-30
CN102065807A (zh) 2011-05-18
IL209755A (en) 2014-06-30
EA026988B1 (ru) 2017-06-30
US20090318847A1 (en) 2009-12-24
CN102065807B (zh) 2014-06-25
US20130245535A1 (en) 2013-09-19

Similar Documents

Publication Publication Date Title
HK1201763A1 (en) Polyamine enhanced formulations for triptan compound iontophoresis
ZA201007686B (en) Amide compound
EP2298731A4 (de) Amidverbindung
EP2320907A4 (de) Therapeutische verbindungen
ZA201103894B (en) Toothbrush
ZA201103891B (en) Toothbrush
EP2141990A4 (de) Aktive 11beta-hsd1-verbindungen
EP2268285A4 (de) Therapeutische verbindungen
ZA201100539B (en) Oxindole compounds
GB0806794D0 (en) Therapeutic compounds
GB0813740D0 (en) Therapeutic compounds
IL206102A0 (en) Crystalline (r)-2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-
GB0804755D0 (en) Therapeutic compounds
GB0804989D0 (en) Compound
EP2284159A4 (de) 5-hydroxypyrimidin-4-carboxamid-verbindung
GB0803494D0 (en) Compound
IL208164A0 (en) Indolinone compound
EP2269485A4 (de) Polyacetal-haltige bürste
GB0811708D0 (en) Brush
ZA201202168B (en) Formulations comprising triptan compounds
GB0816010D0 (en) Toothbrush
GB0816707D0 (en) Therapeutic compounds
GB0821817D0 (en) Therapeutic compounds
GB0811850D0 (en) Therapeutic compounds
GB0815700D0 (en) Therapeutic compounds